vs

Side-by-side financial comparison of First Bancorp, Inc (FNLC) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

First Bancorp, Inc is the larger business by last-quarter revenue ($25.8M vs $13.3M, roughly 2.0× OCULAR THERAPEUTIX, INC). First Bancorp, Inc runs the higher net margin — 39.4% vs -488.0%, a 527.3% gap on every dollar of revenue. On growth, First Bancorp, Inc posted the faster year-over-year revenue change (17.5% vs -22.4%). First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $-57.1M). Over the past eight quarters, First Bancorp, Inc's revenue compounded faster (18.1% CAGR vs -5.3%).

Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

FNLC vs OCUL — Head-to-Head

Bigger by revenue
FNLC
FNLC
2.0× larger
FNLC
$25.8M
$13.3M
OCUL
Growing faster (revenue YoY)
FNLC
FNLC
+40.0% gap
FNLC
17.5%
-22.4%
OCUL
Higher net margin
FNLC
FNLC
527.3% more per $
FNLC
39.4%
-488.0%
OCUL
More free cash flow
FNLC
FNLC
$91.7M more FCF
FNLC
$34.6M
$-57.1M
OCUL
Faster 2-yr revenue CAGR
FNLC
FNLC
Annualised
FNLC
18.1%
-5.3%
OCUL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FNLC
FNLC
OCUL
OCUL
Revenue
$25.8M
$13.3M
Net Profit
$10.2M
$-64.7M
Gross Margin
88.0%
Operating Margin
48.1%
-526.5%
Net Margin
39.4%
-488.0%
Revenue YoY
17.5%
-22.4%
Net Profit YoY
39.7%
-33.6%
EPS (diluted)
$0.91
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FNLC
FNLC
OCUL
OCUL
Q4 25
$25.8M
$13.3M
Q3 25
$24.5M
$14.5M
Q2 25
$22.5M
$13.5M
Q1 25
$21.8M
$10.7M
Q4 24
$22.0M
$17.1M
Q3 24
$20.5M
$15.4M
Q2 24
$19.2M
$16.4M
Q1 24
$18.5M
$14.8M
Net Profit
FNLC
FNLC
OCUL
OCUL
Q4 25
$10.2M
$-64.7M
Q3 25
$9.1M
$-69.4M
Q2 25
$8.1M
$-67.8M
Q1 25
$7.1M
$-64.1M
Q4 24
$7.3M
$-48.4M
Q3 24
$7.6M
$-36.5M
Q2 24
$6.2M
$-43.8M
Q1 24
$6.0M
$-64.8M
Gross Margin
FNLC
FNLC
OCUL
OCUL
Q4 25
88.0%
Q3 25
87.8%
Q2 25
85.6%
Q1 25
88.2%
Q4 24
92.8%
Q3 24
89.9%
Q2 24
90.8%
Q1 24
91.0%
Operating Margin
FNLC
FNLC
OCUL
OCUL
Q4 25
48.1%
-526.5%
Q3 25
45.2%
-472.3%
Q2 25
43.7%
-502.6%
Q1 25
39.3%
-597.5%
Q4 24
39.5%
-296.1%
Q3 24
44.6%
-298.2%
Q2 24
38.8%
-265.1%
Q1 24
39.3%
-214.0%
Net Margin
FNLC
FNLC
OCUL
OCUL
Q4 25
39.4%
-488.0%
Q3 25
37.0%
-477.3%
Q2 25
35.8%
-503.9%
Q1 25
32.5%
-598.7%
Q4 24
33.1%
-283.3%
Q3 24
36.9%
-236.6%
Q2 24
32.1%
-266.3%
Q1 24
32.5%
-438.9%
EPS (diluted)
FNLC
FNLC
OCUL
OCUL
Q4 25
$0.91
$-0.27
Q3 25
$0.81
$-0.38
Q2 25
$0.72
$-0.39
Q1 25
$0.63
$-0.38
Q4 24
$0.66
$-0.25
Q3 24
$0.68
$-0.22
Q2 24
$0.55
$-0.26
Q1 24
$0.54
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FNLC
FNLC
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$737.1M
Total DebtLower is stronger
$95.5M
Stockholders' EquityBook value
$283.1M
$654.3M
Total Assets
$3.2B
$808.1M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FNLC
FNLC
OCUL
OCUL
Q4 25
$737.1M
Q3 25
$344.8M
Q2 25
$391.1M
Q1 25
$349.7M
Q4 24
$392.1M
Q3 24
$427.2M
Q2 24
$459.7M
Q1 24
$482.9M
Total Debt
FNLC
FNLC
OCUL
OCUL
Q4 25
$95.5M
Q3 25
$95.5M
Q2 25
$95.0M
Q1 25
$70.0M
Q4 24
$95.0M
Q3 24
$95.0M
Q2 24
$70.0M
Q1 24
$70.0M
Stockholders' Equity
FNLC
FNLC
OCUL
OCUL
Q4 25
$283.1M
$654.3M
Q3 25
$274.6M
$258.2M
Q2 25
$265.5M
$305.9M
Q1 25
$259.7M
$265.9M
Q4 24
$252.5M
$315.3M
Q3 24
$256.8M
$352.0M
Q2 24
$244.7M
$377.7M
Q1 24
$242.6M
$408.0M
Total Assets
FNLC
FNLC
OCUL
OCUL
Q4 25
$3.2B
$808.1M
Q3 25
$3.2B
$410.9M
Q2 25
$3.2B
$451.3M
Q1 25
$3.2B
$405.9M
Q4 24
$3.2B
$457.9M
Q3 24
$3.1B
$490.4M
Q2 24
$3.1B
$517.1M
Q1 24
$3.0B
$538.9M
Debt / Equity
FNLC
FNLC
OCUL
OCUL
Q4 25
0.34×
Q3 25
0.35×
Q2 25
0.36×
Q1 25
0.27×
Q4 24
0.38×
Q3 24
0.37×
Q2 24
0.29×
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FNLC
FNLC
OCUL
OCUL
Operating Cash FlowLast quarter
$37.8M
$-54.2M
Free Cash FlowOCF − Capex
$34.6M
$-57.1M
FCF MarginFCF / Revenue
133.9%
-430.9%
Capex IntensityCapex / Revenue
12.5%
21.4%
Cash ConversionOCF / Net Profit
3.72×
TTM Free Cash FlowTrailing 4 quarters
$55.3M
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FNLC
FNLC
OCUL
OCUL
Q4 25
$37.8M
$-54.2M
Q3 25
$12.9M
$-50.7M
Q2 25
$7.4M
$-55.2M
Q1 25
$2.2M
$-44.7M
Q4 24
$26.0M
$-39.4M
Q3 24
$9.8M
$-36.6M
Q2 24
$6.4M
$-24.8M
Q1 24
$-1.5M
$-33.9M
Free Cash Flow
FNLC
FNLC
OCUL
OCUL
Q4 25
$34.6M
$-57.1M
Q3 25
$12.6M
$-56.7M
Q2 25
$7.2M
$-56.5M
Q1 25
$828.0K
$-46.6M
Q4 24
$24.6M
$-39.6M
Q3 24
$9.6M
$-36.6M
Q2 24
$6.3M
$-25.5M
Q1 24
$-1.8M
$-34.1M
FCF Margin
FNLC
FNLC
OCUL
OCUL
Q4 25
133.9%
-430.9%
Q3 25
51.4%
-390.0%
Q2 25
32.1%
-419.7%
Q1 25
3.8%
-435.6%
Q4 24
111.7%
-232.0%
Q3 24
47.0%
-237.6%
Q2 24
32.9%
-155.4%
Q1 24
-9.8%
-231.1%
Capex Intensity
FNLC
FNLC
OCUL
OCUL
Q4 25
12.5%
21.4%
Q3 25
1.2%
41.2%
Q2 25
0.6%
9.3%
Q1 25
6.2%
18.1%
Q4 24
6.7%
1.2%
Q3 24
0.5%
0.6%
Q2 24
0.3%
4.5%
Q1 24
1.8%
1.7%
Cash Conversion
FNLC
FNLC
OCUL
OCUL
Q4 25
3.72×
Q3 25
1.42×
Q2 25
0.91×
Q1 25
0.31×
Q4 24
3.58×
Q3 24
1.29×
Q2 24
1.03×
Q1 24
-0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons